Article Versions Notes

Căinap C, Cetean-Gheorghe S, Pop LA, Leucuta DC, Piciu D, Mester A, Vlad C, Ovidiu C, Gherman A, Crişan C, et al. Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia. Medicina. 2021; 57(7):675. https://doi.org/10.3390/medicina57070675

Căinap, Călin, Sânziana Cetean-Gheorghe, Laura Ancuta Pop, Daniel Corneliu Leucuta, Doina Piciu, Andra Mester, Cătălin Vlad, Crişan Ovidiu, Alexandra Gherman, Cristina Crişan, and et al. 2021. "Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia" Medicina 57, no. 7: 675. https://doi.org/10.3390/medicina57070675

Căinap, C., Cetean-Gheorghe, S., Pop, L. A., Leucuta, D. C., Piciu, D., Mester, A., Vlad, C., Ovidiu, C., Gherman, A., Crişan, C., Bereanu, A., Bălăcescu, O., Constantin, A. M., Dicu, I., Bălăcescu, L., Stan, A., Achimaş-Cadariu, P., & Căinap, S. (2021). Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia. Medicina, 57(7), 675. https://doi.org/10.3390/medicina57070675